Menashe D S, Jacobs S C
Department of Urology, Medical College of Wisconsin, Milwaukee.
J Surg Oncol. 1989 Jul;41(3):160-4. doi: 10.1002/jso.2930410306.
In an attempt to increase the therapeutic index of Cisplatin (CDDP), 29 continuous 48 hour intra-arterial (IA) infusions of 100-150 mg/m2 CDDP were given to 26 patients with bulky stage T3-T4 bladder cancer. Hypogastric artery catheters were placed distal (n = 42) or proximal (n = 7) to the origin of the superior gluteal artery. Atherosclerosis (n = 5) or aneurysm (n = 2) prevented successful IA catheter placement. Catheter maintenance resulted in no bleeding or thromboembolic episodes. Urethral catheters caused two urinary tract infections. Systemic toxicity was mild with on 4/29 infusions resulting in WBC less than 3,000, 3/29 infusions resulting in creatinine elevation, and 1/29 in peripheral neuropathy. Local effects of the IA CDDP included gluteal pain and ecchymosis (n = 1) and moderately disabling lower extremity neuropathies (n = 3). Systemic side effects of CDDP can be diminished by use of IA route of administration and slow continuous infusion.
为提高顺铂(CDDP)的治疗指数,对26例T3 - T4期体积较大的膀胱癌患者进行了29次连续48小时的动脉内(IA)输注,剂量为100 - 150 mg/m² CDDP。臀下动脉导管置于臀上动脉起始部远端(n = 42)或近端(n = 7)。动脉粥样硬化(n = 5)或动脉瘤(n = 2)导致IA导管置入失败。导管维护未导致出血或血栓栓塞事件。尿道导管引起2例尿路感染。全身毒性较轻,29次输注中4次导致白细胞计数低于3000,3次导致肌酐升高,1次导致周围神经病变。IA CDDP的局部影响包括臀痛和瘀斑(n = 1)以及中度致残的下肢神经病变(n = 3)。通过IA给药途径和缓慢持续输注可减轻CDDP的全身副作用。